Grupo NC Executive and Leadership Team

Luciane Desiato, the Chief Executive Officer & Trilingual Executive Secretary at Grupo NC, directs the overarching strategy and operational framework for the Brazilian pharmaceutical leader. Overseeing both B2B and B2C operations, Desiato ensures the company's dual business model effectively delivers innovative healthcare solutions and robust pharmacy retail services across South America and emerging Asian markets. This leadership role involves guiding the company's expansion initiatives and maintaining its commitment to sustainable development and continuous improvement. By aligning corporate objectives with market demands, Luciane Desiato drives the company's mission to make a positive impact. The executive's focus extends to fostering excellence in all operational aspects, ensuring Grupo NC remains at the forefront of the pharmaceutical industry. This involves strategic decision-making that supports both long-term growth and immediate market responsiveness, solidifying the company's position as a major player in Brazil and beyond.

Nicole Da Gama, the Chief Financial Officer, Executive Assistant at Grupo NC, manages the financial health and strategic fiscal planning for the leading Brazilian pharmaceutical company. Da Gama oversees all financial operations, including budgeting, forecasting, and investment strategies, ensuring the company's sustained growth and profitability. This leadership position is crucial for supporting Grupo NC's expansion into Asian markets and maintaining its strong footing in South America. The Chief Financial Officer's responsibilities extend to optimizing financial performance across both B2B and B2C segments, aligning fiscal policies with the company's commitment to sustainable development and operational excellence. By providing critical financial insights, Nicole Da Gama enables informed decision-making that drives innovation in healthcare solutions. This role also involves managing investor relations and ensuring compliance with all regulatory financial requirements, safeguarding the company's assets and reputation.

Danieli Moralez, the Chief Operating Officer at Grupo NC, executes the operational strategies that underpin the company's extensive pharmaceutical manufacturing and retail services. Moralez oversees the day-to-day functions of the factories and pharmacy networks, ensuring efficiency and quality across all production lines and customer touchpoints. This involves managing supply chain logistics, optimizing manufacturing processes, and maintaining high standards of service delivery in both B2B and B2C segments. The Chief Operating Officer's responsibilities are critical to Grupo NC's commitment to operational excellence and sustainable development. By streamlining operations, Moralez directly supports the company's expansion into Asian markets and its strong presence in South America. This leadership position requires meticulous attention to detail and a proactive approach to problem-solving, ensuring seamless integration of new technologies and processes. Danieli Moralez drives the effective implementation of corporate policies, guaranteeing that all operational activities align with the company's core values and market objectives.

Diego Neufert, the Chief Technology Officer at Grupo NC, architects the technological vision and infrastructure supporting the company's pharmaceutical innovation and retail operations. Neufert leads the integration of advanced technologies across manufacturing, research and development, and customer-facing platforms, driving efficiency and enhancing the delivery of healthcare solutions. This role is pivotal in advancing Grupo NC's commitment to responsible innovation and sustainable development. By overseeing digital transformation initiatives, Diego Neufert ensures the company remains competitive in both established South American markets and expanding Asian territories. The Chief Technology Officer's purview includes cybersecurity, data management, and the development of scalable IT systems that support the company's dual B2B and B2C business models. Neufert's strategic direction enables Grupo NC to leverage technology for improved product development, streamlined supply chains, and enhanced customer experiences, solidifying the company's market leadership.